Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis

Clinical Reviews in Allergy and Immunology

Volumn 48, Issue 2-3, 2015, Pages 192-197

  Floreani, Annarosa ^a   Franceschet, Irene ^a   Cazzagon, Nora ^a   Spinazzè, Alice ^a   Buja, Alessandra ^a   Furlan, Patrizia ^a   Baldo, Vincenzo ^a   Gershwin, M Eric ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune diseases; PBC; Scleroderma; Sjogren s syndrome

Indexed keywords

ADULT; AGED; ANIMAL; AUTOIMMUNE DISEASES; AUTOIMMUNITY; FEMALE; HUMAN; IMMUNOLOGY; LIVER CIRRHOSIS, BILIARY; MALE; META ANALYSIS; MIDDLE AGED; MORTALITY;

ADULT; AGED; ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED;

EID: 84928995036     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-014-8427-x     Document Type: Article

References (37)

1. Nguyen DL, Juran BD, Lazaridis KN (2010) Primary biliary cirrhosis. Best Pract Res Clin Gastroenterol 24:647–654
2. Teufel A, Weinmann A, Kahaly GJ et al (2010) Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol 44:208–213
3. Trivedi PJ, Hirschfield GM (2012) Review article: overlap syndromes and autoimmune liver disease. Aliment Pharmacol Ther 36:517–533
4. Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E (2011) Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 54:374–385
5. Wang L, Zhang FC, Chen H et al (2013) Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study. World J Gastroenterol 19:5131–5137
6. Ando Y, Yang GX, Kenny TP et al (2013) Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-beta receptor type II mouse. J Autoimmun 41:111–119
7. Ando Y, Yang GX, Tsuda M et al (2012) The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice. Hepatology 56:1418–1426
8. Chen RC, Naiyanetr P, Shu SA et al (2013) Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology 57:1498–1508
9. Jin Q, Moritoki Y, Lleo A et al (2012) Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis. Hepatology 55:1495–1506
10. Leung PS, Wang J, Naiyanetr P et al (2013) Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. J Autoimmun 41:79–86
11. Lleo A, Liao J, Invernizzi P et al (2012) Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 55:153–160
12. Podda M, Selmi C, Lleo A, Moroni L, Invernizzi P (2013) The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. J Autoimmun 46:81–87
13. Takahashi T, Miura T, Nakamura J et al (2012) Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis. Hepatology 55:846–855
14. Tanaka H, Yang GX, Iwakoshi N et al (2013) Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. Clin Exp Immunol 174:364–371
15. Tsuda M, Zhang W, Yang GX et al (2013) Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFbeta receptor type II mice. Hepatology 57:806–816
16. Wang Q, Selmi C, Zhou X et al (2013) Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 41:140–145
17. You Z, Wang Q, Bian Z et al (2012) The immunopathology of liver granulomas in primary biliary cirrhosis. J Autoimmun 39:216–221
18. Floreani A, Caroli D, Variola A et al (2011) A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver Int 31:361–368
19. Scheuer P (1967) Primary biliary cirrhosis. Proc R Soc Med 60:1257–1260
20. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
21. LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205
22. Petri M, Orbai AM, Alarcon GS et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686
23. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347
24. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A (1989) Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 10:1–7
25. Conn HO, Leevy CM, Vlahcevic ZR et al (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 72:573–583
26. Alarcon-Segovia D, Diaz-Jouanen E, Fishbein E (1973) Features of Sjogren’s syndrome in primary biliary cirrhosis. Ann Intern Med 79:31–36
27. Crowe JP, Christensen E, Butler J et al (1980) Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology 78:1437–1441
28. Golding PL, Bown R, Mason AM, Taylor E (1970) “Sicca complex” in liver disease. Br Med J 4:340–342
29. Tsianos EV, Hoofnagle JH, Fox PC et al (1990) Sjogren’s syndrome in patients with primary biliary cirrhosis. Hepatology 11:730–734
30. Fox RI (2005) Sjogren’s syndrome. Lancet 366:321–331
31. Selmi C, Meroni PL, Gershwin ME (2012) Primary biliary cirrhosis and Sjogren’s syndrome: autoimmune epithelitis. J Autoimmun 39:34–42
32. Rigamonti C, Shand LM, Feudjo M et al (2006) Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut 55:388–394
33. Floreani A, Betterle C, Baragiotta A et al (2002) Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis 34:258–261
34. Lawson A, West J, Aithal GP, Logan RF (2005) Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association. Aliment Pharmacol Ther 21:401–405
35. Kubo S, Iwata S, Saito K, Tanaka Y (2011) Successful treatment of primary biliary cirrhosis with etanercept in a patient with rheumatoid arthritis. Joint Bone Spine 78:535–536
36. Spadaro A, Scrivo R, Riccieri V, Valesini G (2008) Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis. Joint Bone Spine 75:87–89
37. Imam MH, Talwalkar JA, Lindor KD (2013) Clinical management of autoimmune biliary diseases. J Autoimmun 46:88–96